PT  - JOURNAL ARTICLE
AU  - Cyrus, Elena
AU  - Clarke, Rachel
AU  - Hadley, Dexter
AU  - Bursac, Zoran
AU  - Trepka, Mary Jo
AU  - Dévieux, Jessy G.
AU  - Bagci, Ulas
AU  - Furr-Holden, Debra
AU  - Coudray, Makella
AU  - Mariano, Yandra
AU  - Kiplagat, Sandra
AU  - Noel, Ines
AU  - Ravelo, Gira
AU  - Paley, Michelle
AU  - Wagner, Eric F.
TI  - The impact of COVID-19 on African American communities in the United States
AID  - 10.1101/2020.05.15.20096552
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.15.20096552
4099  - http://medrxiv.org/content/early/2020/05/19/2020.05.15.20096552.short
4100  - http://medrxiv.org/content/early/2020/05/19/2020.05.15.20096552.full
AB  - Importance The novel Coronavirus Disease 2019 (COVID-19), declared a pandemic in March 2020, may present with disproportionately higher rates in underrepresented racial/ethnic minority populations in the United States, including African American communities who have traditionally been over-represented in negative health outcomes.Study Objective To understand the impact of the density of African American communities (defined as the percentage of African Americans in a county) on COVID-19 prevalence and death rate within the three most populous counties in each U.S. state and territory (n=152).Design An ecological study using linear regression was employed for the study.Setting The top three most populous counties of each U.S. state and territory were included in analyses for a final sample size of n=152 counties.Participants Confirmed COVID-19 cases and deaths that were accumulated between January 22, 2020 and April 12, 2020 in each of the three most populous counties in each U.S. state and territory were included.Main outcome measures Linear regression was used to determine the association between African American density and COVID-19 prevalence (defined as the percentage of cases for the county population), and death rate (defined as number of deaths per 100,000 population). The models were adjusted for median age and poverty.Results There was a direct association between African American density and COVID-19 prevalence; COVID-19 prevalence increased 5% for every 1% increase in county AA density (p<.01). There was also an association between county AA density and COVID-19 deaths, such; the death rate increased 2 per 100,000 for every percentage increase in county AA density (p=.02).Conclusion These study findings indicate that communities with a high African American density have been disproportionately burdened with COVID-19. Further study is needed to indicate if this burden is related to environmental factors or individual factors such as types of employment or comorbidities that members of these community have.Question What is the impact of the density of African American communities (defined as the percentage of African Americans in a county) on COVID-19 prevalence and death rate by U.S. counties.Findings This ecological study including the three most populous counties in each U.S. state and territory, found that COVID-19 prevalence increased 5% for every percentage increase in county African American density, and that the death rate increased 2 per hundred thousand for every percentage increase in county African American density. Both were statistically significant increases.Meaning These study findings indicate that communities with a high African American density have been disproportionately burdened with COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementThe project was supported by Award Number from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health and Award K99DA046311; NIMHD 1 S21 MD010683-01; NIMHD U54MD002266; NIMHD U54MD012393 and NIAAA U34AA026219. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in USA Facts at https://usafacts.org/visualizations/coronavirus-covid-19-spread-map/ and U.S. Census at census.gov. (reference number: 18, 19). https://usafacts.org/visualizations/coronavirus-covid-19-spread-map/ https://www.census.gov